Cohort Study of Pancreatic Cancer Risk

Active, not recruitingOBSERVATIONAL
Enrollment

419

Participants

Timeline

Start Date

December 11, 2019

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Familial Pancreatic Cancer
Trial Locations (1)

55902

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER

NCT04247503 - Cohort Study of Pancreatic Cancer Risk | Biotech Hunter | Biotech Hunter